IBRX rises on cancer vaccine trial milestone update
IBRX shares are heading for their best week in over two months after a cancer vaccine trial milestone update tied to Chairman Soon Shiong.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.